University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides ...

The FDA has approved Tyzavan, a novel ready-to-infuse, room temperature stable formulation of vancomycin, for the treatment of various bacterial infections.

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Many antimicrobial resistant pathogens are more prevalent in patients with cancer than in those without, even in the ...

Following successful trials at Geisinger Medical Center and Geisinger Wyoming Valley Medical Center, the health system will ...

Some medications can make you feel tired or fatigued—but antibiotics typically aren’t one of them. However, some people still report feeling this way during their course of treatment. In some cases, ...

The Business Research Company's Antibacterial Orthopedic Implant Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% on all global market reports with code ONLINE30 ...

Effect of the vancomycin minimum inhibitory concentration on clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis ...

Trends in AMR-related hospitalizations over the past decade were inconsistent and varied by causative pathogen, indicating the overall burden of AMR remains substantial.